Search
Menu
Home
HTB
2018
July
11
11 July 2018
Contents
Editorial
11 July 2018: vol 19 no 12: DTG and preconception – special report
Special reports
HIV pipeline 2018: full version
Dolutegravir preconception signal: time is up for shoddy surveillance
Conference reports
AIDS 2018: Programme online and late-breaker highlights announced three weeks before the conference
Antiretrovirals
Bictegravir/FTC/TAF (Biktarvy) approved in Europe
Women's health
Dolutegravir: need to consider all pros and cons before switching in pregnancy
Pregnancy
Why U=U does not apply to breastfeeding
PDFs
11 July 2018: vol 19 no 12
HTB RSS
Early access
Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study
12 February 2025
IAS public letter: Why HIV could be poised for a monumental comeback
6 February 2025
Lenacapavir for PrEP submitted to EMA for EU and global use
4 February 2025
New mpox vaccination sites open in the UK
3 February 2025
All early access reports
Current issues
February 2025
January 2025
December 2024
Back issues
Special report
Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions
1 February 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate